| scholarly article | Q13442814 |
| P50 | author | Gavin R Screaton | Q42305839 |
| Daniel L. Kastner | Q96817021 | ||
| P2093 | author name string | Keith M Hull | |
| Richard M Siegel | |||
| Adrian A Lobito | |||
| Fiona C Kimberley | |||
| Jagan R Muppidi | |||
| Hirsh Komarow | |||
| Adrianna J Jackson | |||
| P2860 | cites work | Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations | Q22254363 |
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder | Q24317771 | ||
| The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation | Q24318742 | ||
| TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex | Q24329065 | ||
| Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes | Q24329184 | ||
| The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers | Q24535763 | ||
| Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation | Q27732032 | ||
| The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity | Q28139188 | ||
| Aggresomes: a cellular response to misfolded proteins | Q28292275 | ||
| Quality control in the endoplasmic reticulum | Q29619929 | ||
| Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein | Q30782936 | ||
| Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant | Q33740535 | ||
| A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling | Q33907802 | ||
| Tumor necrosis factor signaling. | Q34185821 | ||
| Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance | Q34389314 | ||
| The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder | Q34917526 | ||
| ER stress and the unfolded protein response | Q35986601 | ||
| Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors | Q36017850 | ||
| Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition | Q37544531 | ||
| Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. | Q39869036 | ||
| Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression | Q40373606 | ||
| Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. | Q40499389 | ||
| Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. | Q40515875 | ||
| Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. | Q40525423 | ||
| Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression | Q40536268 | ||
| The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail. | Q40734998 | ||
| DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs | Q40740154 | ||
| Golgi membranes are absorbed into and reemerge from the ER during mitosis | Q40909932 | ||
| Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis | Q41714520 | ||
| Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention | Q41829978 | ||
| Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC Studies | Q44705393 | ||
| Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. | Q52553014 | ||
| Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. | Q54806502 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Dynamics and retention of misfolded proteins in native ER membranes | Q57981250 | ||
| Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis | Q68052321 | ||
| A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes | Q73441137 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | periodic fever syndrome | Q3278145 |
| P304 | page(s) | 1320-1327 | |
| P577 | publication date | 2006-05-09 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS) | |
| P478 | volume | 108 |
| Q30480632 | A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease |
| Q40356949 | A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases |
| Q34851612 | A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS) |
| Q38926349 | Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists |
| Q36520994 | Autoinflammatory disease reloaded: a clinical perspective |
| Q36714318 | Autoinflammatory diseases |
| Q37128189 | Autoinflammatory diseases: an update of clinical and genetic aspects |
| Q40323762 | Autoinflammatory syndromes |
| Q40326095 | Autoinflammatory syndromes/fever syndromes |
| Q47434993 | Autophagy dysfunction in autoinflammatory diseases |
| Q27011650 | Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence |
| Q39411661 | Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion |
| Q38814103 | Canakinumab for the treatment of TNF-receptor associated periodic syndrome |
| Q37604702 | Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome |
| Q39025066 | Causes and consequences of endoplasmic reticulum stress in rheumatic disease |
| Q39663372 | Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide Survey. |
| Q37349814 | Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus |
| Q40297017 | Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study |
| Q34006517 | Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome |
| Q39387054 | Cysteines as Redox Molecular Switches and Targets of Disease |
| Q40129844 | Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome. |
| Q37438706 | Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study |
| Q36347085 | Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells |
| Q51647360 | FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome. |
| Q34657952 | Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome |
| Q40415799 | Fifth International Congress on Familial Mediterranean Fever and Systemic Autoinflammatory Diseases |
| Q37142878 | Genetic defects of apoptosis and primary immunodeficiency |
| Q89819649 | Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases |
| Q24631660 | Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) |
| Q34262561 | IL-1 blockade in autoinflammatory syndromes |
| Q37696955 | IL-1 pathways in inflammation and human diseases |
| Q40368852 | Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome |
| Q50152542 | Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three TNFRSF1A Mutations Results in Hyperresponsiveness to Lipopolysaccharide |
| Q30352433 | Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders. |
| Q38220758 | Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome |
| Q26827163 | Lighting the fires within: the cell biology of autoinflammatory diseases |
| Q35038000 | Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene |
| Q40368922 | Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome |
| Q34681297 | Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS) |
| Q36041225 | Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling |
| Q38211947 | Monogenic autoinflammatory diseases |
| Q37162157 | Monogenic autoinflammatory diseases: concept and clinical manifestations |
| Q37466515 | Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation |
| Q34489840 | Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis |
| Q38253392 | New players driving inflammation in monogenic autoinflammatory diseases |
| Q34560380 | Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes |
| Q40395893 | Periodic fever syndrome/autoinflammatory syndrome |
| Q24645726 | Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee |
| Q38494648 | Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond |
| Q55260956 | Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity. |
| Q40337517 | Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. |
| Q33352461 | Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis |
| Q35623130 | Sensors of the innate immune system: their link to rheumatic diseases |
| Q37834022 | Setting up TRAPS. |
| Q92517067 | Somatic mosaicism in adult-onset TNF receptor-associated periodic syndrome (TRAPS) |
| Q58564753 | Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking |
| Q84090099 | TNFRSF1A [corrected] R92Q mutation, autoinflammatory symptoms and multiple sclerosis in a cohort from Argentina |
| Q40007928 | The C-terminal domain of TRPV4 is essential for plasma membrane localization |
| Q36931672 | The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self |
| Q40263235 | The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still's disease. |
| Q57160539 | The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders |
| Q38389302 | The inflammasome and IL-1β: implications for the treatment of inflammatory diseases. |
| Q39443996 | The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation |
| Q35559391 | The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway |
| Q36048259 | The spectrum of autoinflammatory diseases: recent bench to bedside observations |
| Q37208960 | The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies |
| Q64083535 | Treating TNF Receptor Associated Periodic Fever Syndrome in End-Stage Renal Failure |
| Q40391870 | Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment |
| Q38037377 | Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature |
| Q38202563 | Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases |
| Q40447359 | Tumor necrosis factor receptor-associated periodic syndrome with a C30R mutation in a Japanese family. |
| Q42554360 | Tumor necrosis factor receptor-associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases |
| Q38850188 | Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome |
| Q35485350 | Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. |
| Q40358488 | Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series |
| Q83811771 | [Autoinflammatory syndromes] |
Search more.